Universal Ibogaine Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 14

Employees

  • Stock Symbol
  • IBO

Stock Symbol

  • Investments
  • 3

Universal Ibogaine General Information

Description

Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Suite 1470, Devon Tower
  • 400 3rd Avenue South West
  • Calgary, Alberta T2P 4H2
  • Canada
+1 (855)
Primary Industry
Other Healthcare Services
Stock Exchange
TSX
Corporate Office
  • Suite 1470, Devon Tower
  • 400 3rd Avenue South West
  • Calgary, Alberta T2P 4H2
  • Canada
+1 (855)

Universal Ibogaine Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Universal Ibogaine Stock Performance

As of 02-Feb-2026, Universal Ibogaine’s current market cap is $1.15M with 313M shares.

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.15M 313M 498K -$0.01

Universal Ibogaine Financials Summary

As of 30-Apr-2025, Universal Ibogaine has a trailing 12-month revenue of $1.48M.

In Thousands,
USD
TTM 30-Apr-2025 FY 2024 31-Jul-2024 FY 2023 31-Jul-2023 FY 2022 31-Jul-2022
EV 7,818 5,002 3,901 5,883
Revenue 1,476 1,715 767 843
EBITDA (699) (1,137) (1,471) (8,001)
Net Income (1,057) (1,509) (1,779) (8,264)
Total Assets 2,897 3,258 4,151 4,874
Total Debt 1,859 1,916 2,095 1,341
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Universal Ibogaine Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Universal Ibogaine‘s full profile, request access.

Request a free trial

Universal Ibogaine Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Universal Ibogaine Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Universal Ibogaine‘s full profile, request access.

Request a free trial

Universal Ibogaine Acquisitions (3)

Universal Ibogaine’s most recent deal was a Merger/Acquisition with P Squared Renewables. The deal was made on 02-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
P Squared Renewables 02-Sep-2021 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
Kelburn Recovery Centre 31-Aug-2021 Merger/Acquisition Clinics/Outpatient Services
Universal Ibogaine Belize 01-Jan-2020 Merger/Acquisition Holding Companies
To view Universal Ibogaine’s complete acquisitions history, request access »

Universal Ibogaine ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Universal Ibogaine’s complete esg history, request access »

Universal Ibogaine Exits (1)

Universal Ibogaine’s most recent exit was on 01-Jan-2020 from Universal Ibogaine Belize. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Universal Ibogaine Belize 01-Jan-2020 Completed
To view Universal Ibogaine’s complete exits history, request access »

Universal Ibogaine Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Kelburn Recovery Centre Winnipeg, Canada 2014

Universal Ibogaine FAQs

  • When was Universal Ibogaine founded?

    Universal Ibogaine was founded in 2017.

  • Where is Universal Ibogaine headquartered?

    Universal Ibogaine is headquartered in Calgary, Canada.

  • What is the size of Universal Ibogaine?

    Universal Ibogaine has 14 total employees.

  • What industry is Universal Ibogaine in?

    Universal Ibogaine’s primary industry is Other Healthcare Services.

  • Is Universal Ibogaine a private or public company?

    Universal Ibogaine is a Public company.

  • What is Universal Ibogaine’s stock symbol?

    The ticker symbol for Universal Ibogaine is IBO.

  • What is the current market cap of Universal Ibogaine?

    The current market capitalization of Universal Ibogaine is $1.15M.

  • What is Universal Ibogaine’s current revenue?

    The trailing twelve month revenue for Universal Ibogaine is $1.48M.

  • What is Universal Ibogaine’s annual earnings per share (EPS)?

    Universal Ibogaine’s EPS for 12 months was -$0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process